Common use of Payment for Sponsor Drug or Comparator Drug Clause in Contracts

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer or national payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 5.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or CRO/its designee under this AgreementAgreement 5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee CRO under this Agreement. 5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement4.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement.. 5.5

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 6.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by 4.5. Platba za hodnocený léčivý přípravek nebo srovnávací lék. Poskytovatel a hlavní zkoušející nebudou subjektům klinického hodnocení ani plátcům třetích stran účtovat žádné částky za hodnocený léčivý Sponsor or its designee under this Agreement. přípravek nebo srovnávací lék ani za jakékoliv služby, které mu podle této smlouvy proplácí zadavatel nebo jeho zástupce.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 6.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 5.